Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.
 C Security CSEC 21. jan 2020 0.28 -7.79   
 C-RAD B CRADB 21. jan 2020 50.10 -1.18   
 CAG Group CAG 21. jan 2020 71.50 -0.69   
 Calliditas Therapeutics CALTX 21. jan 2020 83.00 -1.19   
 Calmark B CALMAB 21. jan 2020 5.00 +5.49   
 Camanio Care CARE 21. jan 2020 0.28 +3.68   
 Camurus CAMX 21. jan 2020 95.50 +3.58   
 Cantargia CANTA 21. jan 2020 19.34 +2.33   
 Capacent Holding CAPAC 21. jan 2020 40.00 -1.23   
 Carbiotix CRBX 21. jan 2020 5.74 0.00   
 Castellum CAST 21. jan 2020 227.30 -0.26   
 Catella A CATA 21. jan 2020 29.60 +1.37   
 Catella B CATB 21. jan 2020 29.65 +1.72   
 Catena CATE 21. jan 2020 421.00 -0.94   
 Catena Media CTM 21. jan 2020 34.74 -1.36   
 Cavotec SA CCC 21. jan 2020 20.10 -1.95   
 Cell Impact B CIB 21. jan 2020 22.80 +5.07   
 CellaVision CEVI 21. jan 2020 373.00 -1.45   
 CELLINK B CLNKB 21. jan 2020 102.20 +0.20   
 Cereno Scientific B CRNOB 21. jan 2020 3.45 -5.22   
 CGit B CGITB 21. jan 2020 60.50 -11.03   
 Challenger Mobile B CHALB 21. jan 2020 0.04 -18.37   
 Chordate Medical Holding CMH 21. jan 2020 0.83 +0.24   
 Christian Berner Tech Trade B CBTTB 21. jan 2020 29.40 +0.34   
 ChromoGenics CHRO 21. jan 2020 0.47 -1.46   
 Cibus Nordic Real Estate CIBUS 21. jan 2020 154.00 -0.65   
 Cimco Marine CIMCO 21. jan 2020 1.49 +1.36   
 Clas Ohlson B CLASB 21. jan 2020 107.40 -0.56   
 Clavister Holding CLAV 21. jan 2020 14.95 +1.01   
 Clean Motion CLEMO 21. jan 2020 2.15 +1.90   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK